This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
Day 2 at the 2017 annual meeting of the American Society of Clinical Oncology further highlighted immunotherapy's potential to treat many of the most common types of cancer. Here is an overview of the data coming out of today's session:
Multiple Tumor Types:
Bladder Cancer:
Brain Cancer:
Breast Cancer:
Cervical Cancer:
Childhood Cancer:
Colorectal Cancer:
Esophageal Cancer:
Leukemia:
Liver Cancer:
Lung Cancer:
Melanoma:
Multiple Myeloma:
Ovarian Cancer:
Pancreatic Cancer:
Sarcoma:
Stomach & Gastrointestinal Cancer:
Come back for more updates from tomorrow's presentations.
June is Cancer Immunotherapy Month
Read Previous Article
ASCO17: Day 2 Immunotherapy Highlights
Read Next Article
Contact Us
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Staff Directory
Cancer is not “one-size-fits-all” and neither are its treatments, especially when it comes to immunotherapy. Learn how CRI is helping more people overcome cancer.
Immunotherapy updates from the world's largest cancer conference, the Annual Meeting of the American Society for Clinical Oncology (ASCO).